Cite
Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes.
MLA
Roe, M. T.(Matthew), et al. Creatine Kinase-MB Elevation after Percutaneous Coronary Intervention Predicts Adverse Outcomes in Patients with Acute Coronary Syndromes. 2004. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.ocn929966820&authtype=sso&custid=ns315887.
APA
Roe, M. T. (Matthew), Mahaffey, K. W. (Kenneth), Kilaru, R. (Rakhi), Akkerhuis, K. M. (Martijn), Simoons, M. L. (Maarten), Harrington, R. A. (Robert A., Tardiff, B. E. (Barbara), Granger, C. B. (Christopher), Ohman, E. M. (Magnus), Moliterno, D. J. (David), Lincoff, A. M. (Michael), Califf, R. M. (Robert), Topol, E. J. (Eric), Werf, F. J. J. (Frans) van de, Alexander, J. H. P. (John), & Armstrong, P. W. (Paul). (2004). Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes.
Chicago
Roe, M.T. (Matthew), K.W. (Kenneth) Mahaffey, R. (Rakhi) Kilaru, K.M. (Martijn) Akkerhuis, M.L. (Maarten) Simoons, R.A. (Robert Alex) Harrington, B.E. (Barbara) Tardiff, et al. 2004. “Creatine Kinase-MB Elevation after Percutaneous Coronary Intervention Predicts Adverse Outcomes in Patients with Acute Coronary Syndromes.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.ocn929966820&authtype=sso&custid=ns315887.